{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:00:32Z","timestamp":1790197232102,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018001","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de lutte contre les Cancers et les leuc\u00e9mies de l&apos;Enfant et de l&apos;Adolescent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011074","name":"Universit\u00e9 de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011238","name":"Lions Clubs International Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012094","name":"Children Cancer Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.labinv.2025.104263","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:05:57Z","timestamp":1763654757000},"page":"104263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High Expression of CCL2 Correlated With Dendritic Cell Recruitment in Neuroblastomas Associated With Opsoclonus-Myoclonus Syndrome"],"prefix":"10.1016","volume":"106","author":[{"given":"Maureen","family":"Voirin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-3894","authenticated-orcid":false,"given":"Alexia","family":"Gazeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-3480","authenticated-orcid":false,"given":"Benoit","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-3919","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Voissi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Jannot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Plantaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chastagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Dijoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Caux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-3585","authenticated-orcid":false,"given":"Nathalie","family":"Bendriss-Vermare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-0125","authenticated-orcid":false,"given":"Herv\u00e9","family":"Sartelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2025.104263_bib1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.labinv.2025.104263_bib2","first-page":"114","article-title":"High-risk neuroblastoma treatment review","volume":"5","author":"Smith","year":"2018","journal-title":"Children (Basel)"},{"key":"10.1016\/j.labinv.2025.104263_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y","article-title":"Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2025.104263_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: clinical and biological approach to risk stratification and treatment","volume":"372","author":"Tolbert","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.labinv.2025.104263_bib5","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1002\/cncr.30873","article-title":"Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children\u2019s Oncology Group","volume":"123","author":"Campbell","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2025.104263_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014415","article-title":"Neuroblastoma and MYCN","volume":"3","author":"Huang","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.labinv.2025.104263_bib7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejpn.2009.12.005","article-title":"Opsoclonus-myoclonus in children associated or not with neuroblastoma","volume":"14","author":"Krug","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.labinv.2025.104263_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29949","article-title":"Opsoclonus-myoclonus syndrome associated with neuroblastoma: insights into antitumor immunity","volume":"69","author":"Du","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.labinv.2025.104263_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mpo.1138","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies? A report from the Children\u2019s Cancer Group Study","volume":"36","author":"Rudnick","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.labinv.2025.104263_bib10","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-020-19781-y","article-title":"Cellular and gene signatures of tumor-infiltrating dendritic cells and natural killer cells predict prognosis of neuroblastoma","volume":"11","author":"Melaiu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.labinv.2025.104263_bib11","first-page":"1","article-title":"B cell infiltration is highly associated with prognosis and an immune-infiltrated tumor microenvironment in neuroblastoma","volume":"1","author":"Schaafsma","year":"2021","journal-title":"J Cancer Metastasis Treat"},{"key":"10.1016\/j.labinv.2025.104263_bib12","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3390\/cancers12102912","article-title":"The tumor microenvironment in neuroblastoma: new players, new mechanisms of interaction, and new perspectives","volume":"12","author":"Blavier","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2025.104263_bib13","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.4049\/jimmunol.179.5.3332","article-title":"Tumor-derived chemokine MCP-1\/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells","volume":"179","author":"Brown","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.labinv.2025.104263_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/2767-9764.CRC-21-0134","article-title":"Impaired antitumor immune response in MYCN-amplified neuroblastoma is associated with lack of CCL2 secretion and poor dendritic cell recruitment","volume":"2","author":"Kacher","year":"2022","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.labinv.2025.104263_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpn.2008.04.012","article-title":"Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma","volume":"13","author":"Raffaghello","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.labinv.2025.104263_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.labinv.2025.104263_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.labinv.2025.104263_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.21873\/cgp.20490","article-title":"Regulation and function of CCL2 and N-Myc in retinoic acid-treated neuroblastoma cells","volume":"22","author":"Murra","year":"2025","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.labinv.2025.104263_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112879","article-title":"Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma","volume":"42","author":"Rosenberg","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.labinv.2025.104263_bib20","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI30751","article-title":"Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma","volume":"117","author":"Song","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.labinv.2025.104263_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46968-2","article-title":"Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma","volume":"13","author":"Lascano","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.labinv.2025.104263_bib22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20031462","article-title":"Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2","volume":"199","author":"Metelitsa","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.labinv.2025.104263_bib23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jpedsurg.2014.04.001","article-title":"Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma","volume":"49","author":"Li","year":"2014","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.labinv.2025.104263_bib24","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood-2005-07-2965","article-title":"Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors","volume":"107","author":"Piqueras","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.labinv.2025.104263_bib25","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.gendis.2021.12.020","article-title":"Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma","volume":"9","author":"Liu","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.labinv.2025.104263_bib26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.labinv.2025.104263_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114804","article-title":"A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors","volume":"43","author":"Bonine","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.labinv.2025.104263_bib28","article-title":"The immune cell atlas of human neuroblastoma","volume":"3","author":"Verhoeven","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.labinv.2025.104263_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2020.11.014","article-title":"The immune landscape of neuroblastoma: challenges and opportunities for novel therapeutic strategies in pediatric oncology","volume":"144","author":"Wienke","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.labinv.2025.104263_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccell.2023.12.008","article-title":"Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy","volume":"42","author":"Wienke","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.labinv.2025.104263_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004807","article-title":"Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma","volume":"10","author":"Costa","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.labinv.2025.104263_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722916","article-title":"CCL2: an important mediator between tumor cells and host cells in tumor microenvironment","volume":"11","author":"Jin","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.labinv.2025.104263_bib33","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3389\/fimmu.2019.02759","article-title":"More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis","volume":"10","author":"Gschwandtner","year":"2019","journal-title":"Front Immunol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:28:34Z","timestamp":1773898114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0023683725001734"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104263","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Expression of CCL2 Correlated With Dendritic Cell Recruitment in Neuroblastomas Associated With Opsoclonus-Myoclonus Syndrome","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104263"}}